Filing Flows › Opko Health (OPK) › Q3 2026
Opko Health (OPK) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 4, 2026
Opko Health (OPK) reported revenue of $65.4M for the third quarter 2026 (Q3 2026), +16% from a year earlier and -60% from the quarter before. Operating margin was -48.0%, net loss $53.5M (81.8% of revenue).
Opko Health, Q3 2026: revenue $65.4M (+16% year over year), operating margin -48.0%, net loss $53.5M, operating cash flow −$36.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $65.4M | -60% | +16% |
| Operating profit | −$31.4M | — | -165% |
| Net earnings | −$53.5M | — | -347% |
| Operating cash flow | −$36.3M | — | — |
What changed
Revenue was $65.4M in Q3 2026, up 16% year over year and down 60% from the previous quarter. Product was the largest line at 64% of revenue. License and Service added $4.9M year over year (up 26%), 54% of the total change.
Gross margin was 64.3%, up 2.2 points from Q3 2025. Operating costs exceeded revenue by $31.4M, an operating margin of -48.0%. Operating expenses grew 7% against revenue growth of 16%. The fastest-growing cost line was SG&A (+12%). The quarter ended with a net loss of $53.5M, wider than the previous quarter's $8.4M loss. Net interest and other expense of $29.4M was the main reason.
Operating cash flow was −$36.3M. Non-cash charges added back $22.7M of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items used $7.5M. Capital expenditures of $2.8M exceeded it, leaving free cash flow of −$39.1M.
Questions
What was Opko Health's revenue in the third quarter 2026?
Opko Health (OPK) reported revenue of $65.4M for the third quarter 2026 (Q3 2026), +16% from a year earlier and -60% from the quarter before.
Was Opko Health profitable in the third quarter 2026?
Operating loss was $31.4M (-48.0% of revenue) and net loss $53.5M.
Source: Opko Health 10-Q on SEC EDGAR.